Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 6/2020

01-06-2020 | Bariatric Surgery | Letter to the Editor

The Necessity for Routine Administration of Ursodeoxycholic Acid After Bariatric Surgery

Authors: Dimitrios E. Magouliotis, Grigorios Christodoulidis, Dimitris Zacharoulis

Published in: Obesity Surgery | Issue 6/2020

Login to get access

Excerpt

We read with great interest the article by Sneineh et al. [1] evaluating the risk of symptomatic cholelithiasis following bariatric surgery. Given the significance of the presented evidence, we would like to further stress certain points in conjunction with the data reported in our previous meta-analysis [2]. …
Literature
1.
2.
Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: an updated systematic review and meta-analysis. Obes Surg. 27(11):3021–30.
3.
Caruana JA, McCabe MN, Smith AD, et al. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary? Surg Obes Relat Dis. 2005;1:564–7.CrossRef
4.
Papasavas PK, Gagné DJ, Ceppa FA, et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:41–6.CrossRef
5.
Swartz DE, Felix EL. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis. 2005;1:555–60.CrossRef
6.
Sarr MG. Patients developed symptomatic gallstones between 3 and 21months after Roux-en-Ygastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB. Surg Obes Relat Dis. 2006;2(2):233.CrossRef
7.
Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91–7.CrossRef
8.
Moon RC, Teixeira AF, Du Coin C, et al. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis. 2014;10(1):64–8.CrossRef
9.
10.
11.
Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg. 2008;18:1532–8.CrossRef
Metadata
Title
The Necessity for Routine Administration of Ursodeoxycholic Acid After Bariatric Surgery
Authors
Dimitrios E. Magouliotis
Grigorios Christodoulidis
Dimitris Zacharoulis
Publication date
01-06-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04535-y

Other articles of this Issue 6/2020

Obesity Surgery 6/2020 Go to the issue

Original Contributions

Impact of Bariatric Surgery on Clinical, Biochemical, and Hormonal Parameters in Women with Polycystic Ovary Syndrome (PCOS)

Brief Communication

Does Colectomy Improve Type 2 Diabetes?

Original Contributions

Analysis of Trajectories of Care After Bariatric Surgery Using Data Mining Method and Health Administrative Information Systems

Original Contributions

Long-term Impact of Mini-Gastric Bypass on Inflammatory Cytokines in Cohort of Morbidly Obese Patients: a Prospective Study

Letter to the Editor

Letter to the Editor Re: The Impact of Metabolic Syndrome on Patients Undergoing Breast Reduction Surgery

Original Contributions

Bariatric Surgery Outcomes in Patients with Prior Solid Organ Transplantation: an MBSAQIP Analysis